Enfenamic acid

General description This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the

A potent inhibitor of PKC&beta (IC50 = 6 nM), with modest selectivity over PKC&alpha, &gamma, and &epsilon (IC50 = 39, 83, and 110 nM, respectively) at 3 &microM, also inhibits signaling through the Akt pathway suppresses angiogenesis,

A potent inhibitor of PKC&beta (IC50 = 6 nM), with modest selectivity over PKC&alpha, &gamma, and &epsilon (IC50 = 39, 83, and 110 nM, respectively) at 3 &microM, also inhibits signaling through the Akt pathway suppresses angiogenesis,

DescriptionIt is an encapsulated catalyst (EnCat®), wherein palladium acetate is microencapsulated within a polyurea matrix, which prevents palladium leaching.Reaxa TechnologyWhile Pd EnCat 40 shows excellent performance in a variety of

DescriptionIt is an encapsulated catalyst (EnCat®), wherein palladium acetate is microencapsulated within a polyurea matrix, which prevents palladium leaching.Reaxa TechnologyWhile Pd EnCat 40 shows excellent performance in a variety of